Jeremy Shapiro

<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer

Christos S. Karapetis, Shirin Khambata‐Ford, Derek J. Jonker et al. · New England Journal of Medicine · 2008 · 3.6K citations

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer

Jeanne Tie, Joshua D. Cohen, Kamel Lahouel et al. · New England Journal of Medicine · 2022 · 884 citations · Full text

Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a<i>BRCA1</i>or<i>BRCA2</i>Gene Alteration

Wassim Abida, Akash Patnaik, David Campbell et al. · Journal of Clinical Oncology · 2020 · 655 citations · Full text

Activity of Gemcitabine in Patients with Advanced Ovarian Cancer: Responses Seen Following Platinum and Paclitaxel

Jeremy Shapiro, Michael Millward, Danny Rischin et al. · Gynecologic Oncology · 1996 · 256 citations

Advanced Ovarian Cancer, Medicine, Responses Seen +7

<i>PIK3CA, BRAF</i>, and PTEN Status and Benefit from Cetuximab in the Treatment of Advanced Colorectal Cancer—Results from NCIC CTG/AGITG CO.17

Christos S. Karapetis, Derek J. Jonker, Manijeh Daneshmand et al. · Clinical Cancer Research · 2013 · 164 citations